PRESS RELEASE published on 05/07/2026 at 10:11, 6 months 4 days ago Virbac : Déclaration d'actions et de droits de vote 04/2026 Déclaration du nombre total d'actions et de droits de vote pour VIRBAC sur Euronext Paris. Total brut de droits de vote : 12 707 056, Total net : 12 698 020 Euronext Paris Déclaration Droits De Vote Santé Animale VIRBAC
BRIEF published on 04/07/2026 at 11:10, 7 months 4 days ago Virbac : Déclaration sur les droits de vote au 31 mars 2026 Droits De Vote Euronext Actions Finances VIRBAC
BRIEF published on 04/07/2026 at 11:10, 7 months 4 days ago Virbac: Declaration on voting rights as of March 31, 2026 Voting Rights Euronext Actions Finance VIRBAC
PRESS RELEASE published on 04/07/2026 at 11:05, 7 months 4 days ago Virbac : Déclaration d'actions et de droits de votes 03/2026 Déclaration d'actions et de droits de vote pour Virbac, société cotée sur Euronext Paris. Détails sur le nombre total d'actions et de droits de vote. Contact : finances@virbac.com Euronext Paris Déclaration Droits De Vote Santé Animale VIRBAC
PRESS RELEASE published on 03/17/2026 at 19:00, 7 months 24 days ago Virbac: Communiqué de mise à disposition des comptes consolidés au 31 décembre 2025
PRESS RELEASE published on 03/17/2026 at 19:00, 7 months 24 days ago Virbac: Public Release of the Year-End Consolidated Accounts at 31 December 2025
BRIEF published on 12/16/2025 at 09:58, 10 months 26 days ago Virbac Acquires Thyronorm to Combat Feline Hyperthyroidism Veterinary Medicine Animal Health Feline Hyperthyroidism VIRBAC Thyronorm
BRIEF published on 12/16/2025 at 09:58, 10 months 26 days ago Virbac acquiert Thyronorm pour lutter contre l'hyperthyroïdie féline Santé Animale Médecine Vétérinaire VIRBAC Hyperthyroïdie Féline Thyronorm
BRIEF published on 12/16/2025 at 09:58, 10 months 26 days ago Virbac acquiert Thyronorm pour le traitement de l'hyperthyroïdie féline Acquisition Santé Animale VIRBAC Hyperthyroïdie Féline Thyronorm
BRIEF published on 12/16/2025 at 09:58, 10 months 26 days ago Virbac acquires Thyronorm for the treatment of feline hyperthyroidism Acquisition Animal Health Feline Hyperthyroidism VIRBAC Thyronorm
Published on 11/11/2026 at 10:30, 1 hour 19 minutes ago Temas Engages Arcstone Canada for Capital Markets Advisory and Investor-Communications Services
Published on 11/11/2026 at 03:30, 8 hours 19 minutes ago CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary
Published on 11/11/2026 at 00:40, 11 hours 9 minutes ago Upgraded Tunkillia MRE Validates Optimised Scoping Study
Published on 11/10/2026 at 23:30, 12 hours 19 minutes ago CCL Industries Announces 2026 Third Quarter Results
Published on 11/10/2026 at 23:00, 12 hours 49 minutes ago Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/11/2026 at 11:18, 30 minutes ago Original-Research: Cantourage Group SE (von First Berlin Equity Research GmbH): Kaufen
Published on 11/11/2026 at 11:11, 37 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA intends to notify a Restructuring Project under the StaRUG
Published on 11/11/2026 at 10:10, 1 hour 39 minutes ago EQS-Adhoc: Hapag-Lloyd further raises its earnings outlook for the current financial year
Published on 11/11/2026 at 10:00, 1 hour 49 minutes ago GBC AG and Apaton Finance invite investors to the Zefiro Investor Day on November 19, 2026
Published on 11/11/2026 at 09:40, 2 hours 8 minutes ago Disclosure according to Article 5(1)(b) of the EU Regulation No. 596/2014 and Article 2(3) of the Delegated EU Regulation No. 2016/1052 - 1st Interim Report
Published on 11/10/2026 at 18:00, 17 hours 49 minutes ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 18 hours 4 minutes ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 18 hours 14 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 18 hours 17 minutes ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
